Inve US ▾
ASASND

What Ascendis Pharma A/S promised, and what happened

Guidance Tracker · every commitment management made on a call, tracked from the quarter it was made

Guidance

What management said, and what became of it

17 of 17 judged targets kept · 17 open · verdicts reflect calls analysed to Jun 2026.

TargetOriginal wordingSaidLatest callVerdict
COACH trial enrollment completionComplete enrollment in COACH trialJun 2024Jun 2026:Our recent week 78 cost tried data show sustained efficacy over 78 weeks.
Call transcript, Jun 2026 · no direct link		Achieved
Cash flow from operating activities> EUR 500 millionJun 2026Jun 2026:Even with these investments, we expect to generate more than EUR 500 million in cash flow from operating activities this year.
Call transcript, Jun 2026 · no direct link		New

A verdict describes what became of management’s own words in later analysed calls. “Delayed” is a change of date, “went quiet” a target the calls stopped mentioning. None of it is a judgement on the investment. The methodology sets out how verdicts are recorded.

The full ledger

Open Ascendis Pharma A/S’s full ledger

A free account opens 5 company ledgers a month. All 34 tracked commitments, with each call’s wording and source.

US Pro opens 100 a month, first month free →

The rest of the ledger

Pro opens all 34 tracked commitments for Ascendis Pharma A/S

Above is what the last two calls moved. Pro adds every quarter's revision, the source quote behind each one, and the topics management has stopped answering.

Upgrade to Pro, one month free